Terms: = Brain cancer AND ERCC4, XPF, 2072, ENSG00000175595, Q92889 AND Diagnosis
4 results:
1. Incidental findings on 3 T neuroimaging: cross-sectional observations from the population-based Rhineland Study.
Lohner V; Lu R; Enkirch SJ; Stöcker T; Hattingen E; Breteler MMB
Neuroradiology; 2022 Mar; 64(3):503-512. PubMed ID: 34842946
[TBL] [Abstract] [Full Text] [Related]
2. Xeroderma pigmentosum complementation group F: A rare cause of cerebellar ataxia with chorea.
Carré G; Marelli C; Anheim M; Geny C; Renaud M; Rezvani HR; Koenig M; Guissart C; Tranchant C
J Neurol Sci; 2017 May; 376():198-201. PubMed ID: 28431612
[TBL] [Abstract] [Full Text] [Related]
3. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure.
Jaspers NG; Raams A; Silengo MC; Wijgers N; Niedernhofer LJ; Robinson AR; Giglia-Mari G; Hoogstraten D; Kleijer WJ; Hoeijmakers JH; Vermeulen W
Am J Hum Genet; 2007 Mar; 80(3):457-66. PubMed ID: 17273966
[TBL] [Abstract] [Full Text] [Related]
4. Group characteristics of children with cerebral and spinal cord tumours.
Stewart AM; Lennox EL; Sanders BM
Br J Cancer; 1973 Dec; 28(6):568-74. PubMed ID: 4783157
[TBL] [Abstract] [Full Text] [Related]